Radiating Success: The Growing Market for Radiation Shielding Materials
Posted by MV Mukund on June 11th, 2024
In the rapidly advancing world of medical technology, the radiation shielding material market is experiencing significant growth. Estimated to be worth USD 714 million in 2023, this market is projected to reach USD 980 million by 2028, expanding at a robust CAGR of 6.5% during this period. This surge is driven by the increasing use of nuclear medicine and radiation therapy for both diagnosis and treatment, particularly in the context of rising cancer incidences globally.
Driving Forces Behind Market Growth
1. Rising Demand for Particle Therapy:
Particle therapy, notably proton therapy, is becoming a preferred method for cancer treatment due to its precision and reduced side effects compared to conventional photon therapy. The adoption of such advanced technologies is growing, with the number of particle therapy centers worldwide increasing from 66 in 2017 to 115 by May 2022. This trend is expected to continue, significantly boosting the demand for radiation shielding materials.
2. Increasing Cancer Cases:
With the global incidence of cancer on the rise, there is a corresponding increase in the need for radiation-based treatments and diagnostics. This trend is particularly notable in regions with high rates of cancer and substantial investments in healthcare infrastructure, such as North America and Europe.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=188449426
Market Dynamics
Opportunities:
The market for radiation shielding materials is ripe with opportunities, particularly due to increased private investments in cancer research and the development of advanced radiotherapy technologies. Governments and private entities are pouring funds into cancer treatment infrastructure, exemplified by significant investments like the USD 45.5 million by the Australian Government for regional radiation treatment centers.
Challenges:
However, the market is not without its challenges. The high cost of lead and other shielding materials poses a significant restraint. Additionally, a shortage of skilled oncologists and radiologists can limit the effective use of radiation therapy technologies, impacting the demand for shielding materials.
Key Segments and Regional Insights
Product Types:
Electromagnetic Radiation Shielding: Expected to grow the fastest due to the rising use of diagnostic imaging procedures and the increasing prevalence of target diseases like cancer and Alzheimer’s.
Particle Radiation Shielding: Continues to be critical, driven by the expanding use of particle therapy.
Applications:
Diagnostic X-ray Room Shielding: Dominates the market due to the extensive use of X-ray technology in diagnostic centers and hospitals.
CT Scanner and MRI Room Shielding: Also significant, with growing installations in healthcare facilities.
Regional Insights:
North America: Leading the market, driven by substantial government and private sector investments in cancer treatment facilities and advanced diagnostic technologies.
Europe and Asia Pacific: Also showing significant growth, with increasing healthcare infrastructure development and rising cancer treatment needs.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=188449426
Leading Market Players:
Prominent companies in this market include ETS-LINDGREN, Nelco Worldwide, Infab Corporation, Burlington Medical, and MarShield, among others. These companies are at the forefront of innovation, offering a wide range of products that cater to the diverse needs of the radiation shielding market.
Future Outlook:
The future of the radiation shielding material market looks promising, with ongoing advancements in radiotherapy technologies and increasing investments in healthcare infrastructure. As the demand for effective cancer treatment continues to rise, the market for radiation shielding materials is expected to grow, offering numerous opportunities for innovation and expansion.
